Sleep drug, Lunesta, to be relabeled with lower starting dose: FDA

PRESS RELEASE The U.S. Food and Drug Administration today announced it required the manufacturer of the sleep drug Lunesta (eszopiclone) to change the drug label and lower the current recommended starting dose. More...